CD&R and McKesson to Acquire Option Care Health for $5.8 Billion
Article excerpt
Highlighted: the sentence this signal was extracted from
Clayton, Dubilier & Rice and McKesson Corporation have agreed to acquire Option Care Health in a $5.8 billion transaction that will take the nation's largest independent home and alternate-site infusion services provider private. Under the definitive agreement, Option Care Health shareholders will receive $32.05 per share in cash. CD&R will own approximately 51% of the company following closing, while McKesson will invest about $1.4 billion for a roughly 49% minority interest. Option Care Health will remain a separate company led by its existing management team. The $32.05-per-share consideration represents an approximately 37% premium to Option Care Health's closing stock price on Oct. 5, 2026, the last full trading day before the transaction was announced. The transaction also establishes a framework that could eventually give McKesson full ownership of Option Care Health. McKesson would have the ability to acquire CD&R's interest in the company in the future, subject to specified conditions and regulatory approvals. Following the initial closing, McKesson plans to account for its investment using the equity method. For McKesson, the investment expands its exposure to specialty pharmaceuticals and healthcare delivery outside traditional hospital settings. Option Care Health provides infusion therapy in patients' homes and at ambulatory sites, giving McKesson a national...
Keep reading with a free account
The rest of this article, and every signal for McKesson, is in your free account.
